[In vitro culture of the primordium or the presumptive territory of the wing of the chick embryo: differentiation of the cartilage].

M. Pinot

1969-04-01

Abstract:

What problem does this paper attempt to address?

Antibiotic‐resistant pneumococci

M. R. Jacobs,P. Appelbaum

DOI: https://doi.org/10.1016/S0031-3955(16)38977-5

1995-04-01

Abstract:
Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold

R. Foy,J. So,E. Rous,J. Howard Scarffe

DOI: https://doi.org/10.1136/bmj.318.7181.456

1999-02-13

British Medical Journal

Abstract:The provision of high quality cancer services is a major priority for the NHS.1 However, greater budgetary pressures are being placed on specialist hospitals and health authorities by several factors: Christie Hospital NHS Trust in Manchester provides specialist cancer care to a population of 4.5million people from North Wales to Cumbria. The trust's drug budget of £4 million accounted for 18% of the total income from patient services in 1996-7,creating an obvious focus for annual negotiations with commissioning health authorities. Historical underfunding of the trust's drug budget, relative to that of other oncology centres, further supported the trust's case for increased resources. Clinicians highlighted the paradox whereby only 1% of the annual NHS drug budget (£58 million) was allocated to cytotoxic drugs for treating a disease that would affect at least one in three of the population, while £200 million was spent on treating constipation.2–4 The trust was concerned that individual health authorities within its catchment area would negotiate different contracts, resulting in inequitable access to new developments, as has previously occurred with cancer treatments.5 A Greater Manchester consortium of six health authorities was established, partly as a response to this and partly to develop more efficient commissioning. The consortium, responsible for purchasing around two thirds of services from the hospital, also advised neighbouring health authorities in the catchment area. It soon became clear that the trust's proposed developments could not be met in full from available resources and the consortium agreed to set priorities in funding drug developments. This paper describes our joint experiences in prioritising drug proposals for 1997-8. ### Summary points
Optics of spectacle lenses intended to treat myopia progression

David A. Atchison,W. Neil Charman

DOI: https://doi.org/10.1097/opx.0000000000002140

2024-06-12

Optometry and Vision Science

Abstract:Myopia has become an increasing health problem worldwide, particularly in some East Asian countries. This has led to many attempts to slow its progression in children. Many of these attempts have involved optical interventions, including blue- and red-light therapies, more outdoor time (increased illumination), orthokeratology (the overnight flattening of the central cornea to make optical correction unnecessary during the day), spectacle lenses, and contact lenses. The theoretical justifications of the last two include (1) that children who go on to develop myopia or already have myopia have poor accommodation response 1 so that the consequent hyperopic defocus with near vision tasks stimulates eye growth 2 and (2) that a relative hyperopic peripheral refraction is the cause of eye growth. The second of these theories is the basis for many of the available treatment options and is supported by animal studies. 3 The foundation of this theory is dubious, 4,5 however, and there is clinical evidence that relative peripheral hyperopia is purely a consequence of the development of myopia and not the other way around. 6–8 – 8 Nevertheless, correction of the relative peripheral hyperopia may still be of benefit, and recent lenses designed in accordance with the theory have established clinical benefits in slowing myopia progression. 9

ophthalmology
Pharmacotherapeutic candidates for myopia: A review

Wen-Yi Wang,Camille Chen,Justine Chang,Lillian Chien,Yung-Feng Shih,Luke L K Lin,Chi Pui Pang,I-Jong Wang,Luke L.K. Lin

DOI: https://doi.org/10.1016/j.biopha.2020.111092

2021-01-01

Abstract:This review provides insights into the mechanism underlying the pathogenesis of myopia and potential targets for clinical intervention. Although the etiology of myopia involves both environmental and genetic factors, recent evidence has suggested that the prevalence and severity of myopia appears to be affected more by environmental factors. Current pharmacotherapeutics are aimed at inhibiting environmentally induced changes in visual input and subsequent changes in signaling pathways during myopia pathogenesis and progression. Recent studies on animal models of myopia have revealed specific molecules potentially involved in the regulation of eye development. Among them, the dopamine receptor plays a critical role in controlling myopia. Subsequent studies have reported pharmacotherapeutic treatments to control myopia progression. In particular, atropine treatment yielded favorable outcomes and has been extensively used; however, current studies are aimed at optimizing its efficacy and confirming its safety. Furthermore, future studies are required to assess the efficacy of combinatorial use of low-dose atropine and contact lenses or orthokeratology.

pharmacology & pharmacy,medicine, research & experimental
Regulation of renal functional development.

W. Mccrory

IF: 2.766

Urologic Clinics of North America

Abstract:An explanation of the functional development of the renal system is offered, with particular emphasis on glomerular fitration, renal vascular resistance, the development of the renal tubules, and quantitative measurement of renal obstruction.
[Insulin of man and human insulins. Medical and economic aspects in 1987].

L. Perlemuter

1988-03-05

Presse Medicale

Abstract:
Animal modeling for myopia

Lingman Zheng,Zhiyong Liao,Jian Zou

DOI: https://doi.org/10.1016/j.aopr.2024.06.001

2024-06-05

Abstract:Background: Myopia is one of the most common eye diseases globally, and has become an increasingly serious health concern among adolescents. Understanding the factors contributing to the onset of myopia and the strategies to slow its progression is critical to reducing its prevalence. Main text: Animal models are key to understanding of the etiology of human diseases. Various experimental animal models have been developed to mimic human myopia, including chickens, rhesus monkeys, marmosets, mice, tree shrews, guinea pigs and zebrafish. Studies using these animal models have provided evidences and perspectives on the regulation of eye growth and refractive development. This review summarizes the characteristics of these models, the induction methods, common indicators of myopia in animal models, and recent findings on the pathogenic mechanism of myopia. Conclusions: Investigations using experimental animal models have provided valuable information and insights into the pathogenic mechanisms of human myopia and its treatment strategies.
Nutrition of Australian Aboriginal infants and children

M. Gracey

DOI: https://doi.org/10.1111/j.1440-1754.1991.tb02536.x

1991-10-01

Journal of Paediatrics and Child Health

Abstract:Adequate nutrition is essential for normal growth during childhood. This is so important that the United Nations has included ‘provision of adequate nutrition’ in their International Declaration of the Rights of the Child. For paediatricians, satisfactory growth is the most important, practical indicator of adequate nutrition but growth is affected by other genetic and environmental factors, particularly repeated or chronic infection.
Light and myopia: from epidemiological studies to neurobiological mechanisms

Arumugam R. Muralidharan,Carla Lança,Sayantan Biswas,Veluchamy A. Barathi,Low Wan Yu Shermaine,Saw Seang-Mei,Dan Milea,Raymond P. Najjar

DOI: https://doi.org/10.1177/25158414211059246

2021-01-01

Therapeutic Advances in Ophthalmology

Abstract:Myopia is far beyond its inconvenience and represents a true, highly prevalent, sight-threatening ocular condition, especially in Asia. Without adequate interventions, the current epidemic of myopia is projected to affect 50% of the world population by 2050, becoming the leading cause of irreversible blindness. Although blurred vision, the predominant symptom of myopia, can be improved by contact lenses, glasses or refractive surgery, corrected myopia, particularly high myopia, still carries the risk of secondary blinding complications such as glaucoma, myopic maculopathy and retinal detachment, prompting the need for prevention. Epidemiological studies have reported an association between outdoor time and myopia prevention in children. The protective effect of time spent outdoors could be due to the unique characteristics (intensity, spectral distribution, temporal pattern, etc.) of sunlight that are lacking in artificial lighting. Concomitantly, studies in animal models have highlighted the efficacy of light and its components in delaying or even stopping the development of myopia and endeavoured to elucidate possible mechanisms involved in this process. In this narrative review, we (1) summarize the current knowledge concerning light modulation of ocular growth and refractive error development based on studies in human and animal models, (2) summarize potential neurobiological mechanisms involved in the effects of light on ocular growth and emmetropization and (3) highlight a potential pathway for the translational development of noninvasive light-therapy strategies for myopia prevention in children.
Epidemiology of Myopia

Pei-Chang Wu,Hun-Ju Yu,Po-Chiung Fang,Hsiu-Mei Huang,Chueh-tan Chen

DOI: https://doi.org/10.1097/APO.0000000000000236

2016-11-01

Asia-Pacific Journal of Ophthalmology

Abstract:AbstractMyopia is not a simple refractive error, but an eyesight-threatening disease. There is a high prevalence of myopia, 80% to 90%, in young adults in East Asia; myopia has become the leading cause of blindness in this area. As the myopic population increases globally, the severity of its impact is predicted. Approximately one fifth of the myopic population has high myopia (≥−6 diopters), which results in irreversible vision loss such as retinal detachment, choroidal neovascularization, cataracts, glaucoma, and macular atrophy. The increasing prevalence of school myopia in the past few decades may be a result of gene-environment interactions. However, earlier school myopia onset would accompany faster myopia progression and greater risk of high myopia later in life. Recently, there have been effective interventions to delay the onset of myopia, such as outdoor activity and decreasing the duration of near work. Hyperopia (⩽0.5 diopters) is a predictor of myopia. Pharmacological agents and optic interventions such as low-concentration atropine and orthokeratology may slow progression in myopic children. Novel surgeries and anti–vascular endothelial growth factor drugs could deal with some myopic complications. From available evidence, the prevention, control, and treatment of myopia seem to be promising. However, to reduce the impact of myopia in future decades, more work and effort are still needed, including that by governments and intercountry eye health organizations.

Medicine
Strength and lactone formation of gluconic acid.

L. Skibsted,G. Kilde

Abstract:
The cause of myopia development and progression: Theory, evidence, and treatment

Antonio Medina

DOI: https://doi.org/10.1016/j.survophthal.2021.06.005

Abstract:I review the key findings and our current knowledge of the cause of myopia, making the connections among the reliable observations on myopia development and theory to arrive at a summary of what we know about myopia, the proposed prevailing theory, and applicable action. Myopia is reaching epidemic proportions. It is estimated that half of the world's population will be myopic by 2050 unless new strategies to fight myopia are developed. Our high-level mathematical description of myopia is translated into clinical applications involving effective treatment and prevention. A regulating mechanism controlling the refraction of the eye is intimately related to myopia. The approach at hand is to review our knowledge about emmetropization, connecting myopia and emmetropization feedback theory to unveil the cause of myopia. Many observations discussed here test the validity of feedback theory positively. The cause of human myopia fits perfectly with the idea that emmetropization, in particular its feedback theory implementation, is the controlling mechanism behind myopia. They include near work, atropine, lenses, defocus, and outdoor versus indoor activities. The key findings in myopia research point the same way: myopia is the result of corrective lenses interfering with emmetropization. We have enough knowledge to answer the question of whether myopia can be reversed or prevented. There is no need to have mathematical skills to apply theory to real cases. It is enough to know the predictions of the feedback theory of emmetropization.
Myopia management in the Netherlands

Caroline CW Klaver,Jan Roelof Polling,Erasmus Myopia Research Group,

DOI: https://doi.org/10.1111/opo.12676

2020-03-01

Ophthalmic and Physiological Optics

Abstract:PurposeA trend that myopia is becoming gradually more common is shown in studies worldwide. Highest frequencies have been found in East Asian urban populations (96.5%) but also a study in Europe shows that nearly half of the 25‐29 year olds has myopia. With the increase in prevalence, high myopia, i.e. a spherical equivalent of ‐6 or more and an axial length of 26 mm or more is also on the rise. High myopia particularly carries a significant risk of ocular pathology related to the long axial length. This highlights the need for myopia management in children with progressive myopia, in particular progression to high myopia. Recent findingsDuring the last decade, many intervention studies for myopia progression have emerged. Although lifestyle adjustments are effective, pharmacological and optical interventions have shown the highest efficacy on reduction of eye growth. High concentration atropine (0.5%‐1.0%) shows the most reduction in axial length progression, but has drawbacks of light sensitivity and loss of accommodation. Nevertheless, when these side effects are mitigated by multifocal photochromatic glasses, the long‐term adherence to high dose atropine is high. Lower concentrations of atropine are less effective, but have less side effects. Studies on optical interventions have reported reduction of progression for Ortho‐K and multifocal contact lenses, but are in need for replication in larger studies with longer duration. SummaryThe field of myopia management is rapidly evolving, and a position on the best approach for daily clinics is desirable. Over the last 10 years, our team of clinical researchers has developed a strategy which involves decision‐making based on age, axial length, position on the axial length growth chart, progression rate, risk of high myopia, risk profile based on lifestyle and familial risk, side effects, and individual preference. This personalised approach ensures the most optimal long‐term myopia control, and helps fight against visual impairment and blindness in the next generations of elderly.

ophthalmology
Effectiveness of antiretroviral treatment in a South African program: a cohort study.

L. Fairall,M. Bachmann,G. Louwagie,C. van Vuuren,Perpetual Chikobvu,D. Steyn,Gillian H. Staniland,Venessa Timmerman,Mpumelelo Msimanga,C. Seebregts,A. Boulle,R. Nhiwatiwa,E. Bateman,M. Zwarenstein,Ronald D Chapman

DOI: https://doi.org/10.1001/archinternmed.2007.10

2008-01-14

Archives of Internal Medicine

Abstract:BACKGROUND The effectiveness of the South African government's expanding antiretroviral treatment program is unknown. Observational studies of treatment effectiveness are prone to selection bias, rarely compare patients receiving antiretroviral treatment with similar patients not receiving antiretroviral treatment, and underestimate mortality rates unless patients are actively followed up. METHODS We followed up 14 267 patients in the Public Sector Anti-Retroviral Treatment project in Free State, South Africa, for up to 20 months after enrollment. A total of 3619 patients received highly active triple antiretroviral treatment (HAART) for up to 19 months (median, 6 months; interquartile range, 3-9 months) after enrollment. Patients' clinical data were linked with the national mortality register. Marginal structural regression models adjusted for baseline and time-varying covariates. RESULTS Of 4570 patients followed up for at least 1 year, 53.2% died. Eighty-seven percent of patients who died had not received HAART. HAART was associated with lower mortality (hazard ratio, 0.14; 95% confidence interval [CI], 0.11-0.18) and with the presence of tuberculosis (hazard ratio, 0.61; 95% CI, 0.46-0.81) after adjusting for age, sex, weight, clinic, district, CD4 cell count, cotrimoxazole therapy, tuberculosis at baseline, and previous antiretroviral therapy. Cotrimoxazole therapy was associated with lower mortality (hazard ratio, 0.37; 95% CI, 0.32-0.42). Each month of HAART was associated with an increase in CD4 cell count of 15.1 cells/microL (95% CI, 14.7-15.5 cells/microL) and with an increase in body weight of 602 g (95% CI, 548-658 g). CONCLUSIONS HAART provided through these South African government health services seems as effective as that provided in high-income countries. Delays starting HAART contributed to high mortality rates. Faster expansion and timely commencement of HAART are needed.
Environmental Factors and Myopia: Paradoxes and Prospects for Prevention

Kathryn Ailsa Rose,Amanda Nicole French,Ian George Morgan,Rose, Kathryn Ailsa,French, Amanda Nicole,Morgan, Ian George

DOI: https://doi.org/10.1097/APO.0000000000000233

2019-10-03

Abstract:Abstract The prevalence of myopia in developed countries in East and Southeast Asia has increased to more than 80% in children completing schooling, whereas that of high myopia has increased to 10%–20%. This poses significant challenges for correction of refractive errors and the management of pathological high myopia. Prevention is therefore an important priority. Myopia is etiologically heterogeneous, with a low level of myopia of clearly genetic origins that appears without exposure to risk factors. The big increases have occurred in school myopia, driven by increasing educational pressures in combination with limited amounts of time spent outdoors. The rise in prevalence of high myopia has an unusual pattern of development, with increases in prevalence first appearing at approximately age 11. This pattern suggests that the increasing prevalence of high myopia is because of progression of myopia in children who became myopic at approximately age 6 or 7 because age-specific progression rates typical of East Asia will take these children to the threshold for high myopia in 5 to 6 years. This high myopia seems to be acquired, having an association with educational parameters, whereas high myopia in previous generations tended to be genetic in origin. Increased time outdoors can counter the effects of increased nearwork and reduce the impact of parental myopia, reducing the onset of myopia, and this approach has been validated in 3 randomized controlled trials. Other proposed risk factors need further work to demonstrate that they are independent and can be modified to reduce the onset of myopia.

ophthalmology
Aqueous Humor Protein Markers in Myopia: a Review.

Jiechao Shao,Zongchan Zhang,Xuecheng Cai,Ye Shen,Jianping Tong

DOI: https://doi.org/10.1007/s10792-024-02942-z

2024-01-01

Abstract:PURPOSE:Myopia is one of the most common forms of refractive error. Most myopia manifests itself as a relative growth of the eye axis, resulting in a state in which light is projected in front of the retina after being refracted by the refractive system of the eyeball. So far, the specific pathogenesis of myopia is still not well explained, through the results of animal experiments, researchers have proposed various possible scenarios, but all these are based on animal models, and there may still be a certain gap with the mechanism of true myopia in humans. The most readily available in clinical work is aqueous humor obtained during cataract surgery, for which we reviewed these studies of aqueous humor samples from myopic patients.METHODS:A systematic literature search was done on PubMed using key words including "myopia," "aqueous humor," and "protein."RESULTS:The results of existing aqueous humor studies have shown that the difference in substances in the aqueous humor of myopia is related to the degradation of the scleral matrix, chronic inflammation of the eye, pro-fibrosis, blood vessel production, and inhibition. There may be more than one reason associated with myopia progression.CONCLUSION:The specific mechanism of myopia has not been fully elucidated. Therefore, the means of preventing and treating myopia should focus on inhibiting the degradation of the scleral matrix, promoting the proliferation of scleral collagen fibers, and alleviating chronic inflammation of the eyes. Further research into myopic aqueous humor may provide us with new insights.
Body temperature regulation and outcome after cardiac arrest and therapeutic hypothermia.

Jakobea Benz-Woerner,F. Delodder,R. Benz,Nadine Cueni-Villoz,F. Feihl,A. Rossetti,L. Liaudet,M. Oddo

DOI: https://doi.org/10.1016/j.resuscitation.2011.10.026

IF: 6.251

2012-03-01

Resuscitation

Abstract:
Myopia, what causes it and can it be avoided?

Olavi Pärssinen

DOI: https://doi.org/10.1111/aos.16409

2024-01-01

Acta Ophthalmologica

Abstract:Myopia (short‐sightedness or near‐sightedness) is a condition of refraction where vision to distant is impaired. Axial elongation of the eye is the main anatomical cause of myopia. The prevalence of myopia has increased alarmingly fast globally. The estimation of WHO report was that in 2020 27% of world's population would be myopic, and if there will be no changes in the trend then by 2050 there would be 2.56 billion myopic people worldwide. Highest prevalence of myopia has been reported in many South and East Asian countries, where about 80% of the school leavers are myopic. Parental myopia increases the risks of myopia in their children, two myopic parents more than one. Genetic studies have been able to explain only small part of myopia, nor have been able to explain the differences in the prevalence between populations. Myopia relates to higher education, near work and higher occupational status and is mare rare in urban environment and in occupations where people work outdoors. In children myopia usually develop after they had begun attending school and is associated with more time spent on reading and near work and less time on outdoor activities. The major public health concerns connected with myopia are related to its complications. Myopia has become one of the main causes of vision loss due to complications, such as retinal detachment, macular degeneration and haemorrhage, choroidal neovascularization, and open angle glaucoma. The higher myopia is the higher is the risk of these complications. In countries where myopia is common, it is already a significant cause of low vision and blindness. In a Finnish study prevalence of myopia in 7‐ and 11‐year‐olds, was 0.5% and 3.3%, respectively, if daily near work did not exceed 1 h. Multiple regression model adjusted by sex, parental myopia and time spent outdoors, showed that 1 h increase in near work increased the risk of myopia 47% (95% CI 1.099–1.984, P = 0.010) and 35% (CI 1.170–1.548, P < 0.001), in 7‐ and 11‐year‐olds, respectively. Each hour spent outdoors adjusted by sex, parental myopia and time spent outdoors decreased their same risk by 24% (95% CI 0.533–1050, P = 0.096 and 0.648–0.000, P = 0.001, respectively). Higher prevalence of myopia in girls could mainly be explained by their more time spent in near work and less time outdoors. Plenty of long‐term near viewing, and short viewing distance, combined with low amount of time outdoors are risk factors for myopia. Avoiding these factors is more important the younger the child is. It is recommended that the daily time spent outdoors in children should be at least equal to near work time. Early school starting age, increases the risk of myopia and high myopia, and consequently risk for myopia related complications. Great educational stress in young children should be avoided.

ophthalmology
IMI Prevention of Myopia and Its Progression

Jost B. Jonas,Marcus Ang,Pauline Cho,Jeremy A. Guggenheim,Ming Guang He,Monica Jong,Nicola S. Logan,Maria Liu,Ian Morgan,Kyoko Ohno-Matsui,Olavi Pärssinen,Serge Resnikoff,Padmaja Sankaridurg,Seang-Mei Saw,Earl L. Smith,Donald T. H. Tan,Jeffrey J. Walline,Christine F. Wildsoet,Pei-Chang Wu,Xiaoying Zhu,James S. Wolffsohn

DOI: https://doi.org/10.1167/iovs.62.5.6

2021-04-28

Investigative Opthalmology and Visual Science

Abstract:The prevalence of myopia has markedly increased in East and Southeast Asia, and pathologic consequences of myopia, including myopic maculopathy and high myopia-associated optic neuropathy, are now some of the most common causes of irreversible blindness. Hence, strategies are warranted to reduce the prevalence of myopia and the progression to high myopia because this is the main modifiable risk factor for pathologic myopia. On the basis of published population-based and interventional studies, an important strategy to reduce the development of myopia is encouraging schoolchildren to spend more time outdoors. As compared with other measures, spending more time outdoors is the safest strategy and aligns with other existing health initiatives, such as obesity prevention, by promoting a healthier lifestyle for children and adolescents. Useful clinical measures to reduce or slow the progression of myopia include the daily application of low-dose atropine eye drops, in concentrations ranging between 0.01% and 0.05%, despite the side effects of a slightly reduced amplitude of accommodation, slight mydriasis, and risk of an allergic reaction; multifocal spectacle design; contact lenses that have power profiles that produce peripheral myopic defocus; and orthokeratology using corneal gas-permeable contact lenses that are designed to flatten the central cornea, leading to midperipheral steeping and peripheral myopic defocus, during overnight wear to eliminate daytime myopia. The risk-to-benefit ratio needs to be weighed up for the individual on the basis of their age, health, and lifestyle. The measures listed above are not mutually exclusive and are beginning to be examined in combination.
Advances in myopia control strategies for children

Xiu Juan Zhang,Ebenezer Zaabaar,Amanda Nicole French,Fang Yao Tang,Ka Wai Kam,Clement C Tham,Li Jia Chen,Chi Pui Pang,Jason C Yam

DOI: https://doi.org/10.1136/bjo-2023-323887

2024-05-22

Abstract:Myopia has long been a global threat to public health. Timely interventions are likely to reduce the risk of vision-threatening complications. There are both established and rapidly evolving therapeutic approaches to slow myopia progression and/or delay its onset. The effective methods for slowing myopia progression include atropine eye-drops, defocus incorporated multiple segments (DIMS) spectacle lenses, spectacle lenses with highly aspherical lenslets target (HALT), diffusion optics technology (DOT) spectacle lenses, red light therapy (RLT), multifocal soft contact lenses and orthokeratology. Among these, 0.05% atropine, HALT lenses, RLT and +3.00 peripheral addition soft contact lenses yield over 60% reduction in myopia progression, whereas DIMS, DOT and MiSight contact lenses demonstrate at least 50% myopia control efficacy. 0.05% atropine demonstrates a more optimal balance of efficacy and safety than 0.01%. The efficacy of 0.01% atropine has not been consistent and requires further validation across diverse ethnicities. Combining atropine 0.01% with orthokeratology or DIMS spectacles yields better outcomes than using these interventions as monotherapies. Increased outdoor time is an effective public health strategy for myopia prevention while recent studies suggest that 0.05% low-concentration atropine and RLT therapy have promising potential as clinical myopia prevention interventions for high-risk groups. Myopia control spectacle lenses, being the least invasive, are safe for long-term use. However, when considering other approaches, it is essential to ensure proper instruction and regular follow-ups to maintain safety and monitor any potential complications. Ultimately, significant advances have been made in myopia control strategies, many of which have shown meaningful clinical outcomes. However, regular use and adequate safety monitoring over extended durations are imperative to foster confidence that can only come from extensive clinical experience.

[In vitro culture of the primordium or the presumptive territory of the wing of the chick embryo: differentiation of the cartilage].

Antibiotic‐resistant pneumococci

Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold

Optics of spectacle lenses intended to treat myopia progression

Pharmacotherapeutic candidates for myopia: A review

Regulation of renal functional development.

[Insulin of man and human insulins. Medical and economic aspects in 1987].

Animal modeling for myopia

Nutrition of Australian Aboriginal infants and children

Light and myopia: from epidemiological studies to neurobiological mechanisms

Epidemiology of Myopia

Strength and lactone formation of gluconic acid.

The cause of myopia development and progression: Theory, evidence, and treatment

Myopia management in the Netherlands

Effectiveness of antiretroviral treatment in a South African program: a cohort study.

Environmental Factors and Myopia: Paradoxes and Prospects for Prevention

Aqueous Humor Protein Markers in Myopia: a Review.

Body temperature regulation and outcome after cardiac arrest and therapeutic hypothermia.

Myopia, what causes it and can it be avoided?

IMI Prevention of Myopia and Its Progression

Advances in myopia control strategies for children